Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The first-appearing β-cell autoantibody has been shown to influence risk of type 1 diabetes (T1D). Here, we assessed the risk of autoantibody spreading to the second-appearing autoantibody and further progression to clinical disease in The Environmental Determinants of Diabetes in the Young (TEDDY) study. RESEARCH DESIGN AND METHODS: Eligible children with increased HLA-DR-DQ genetic risk for T1D were followed quarterly from age 3 months up to 15 years for development of a single first-appearing autoantibody (GAD antibody [GADA], insulin autoantibody [IAA], or insulinoma antigen-2 autoantibody [IA-2A]) and subsequent development of a single second-appearing autoantibody and progression to T1D. Autoantibody positivity was defined as positivity for a specific autoantibody at two consecutive visits confirmed in two laboratories. Zinc transporter 8 autoantibody (ZnT8A) was measured in children who developed another autoantibody. RESULTS: There were 608 children who developed a single first-appearing autoantibody (IAA, n = 282, or GADA, n = 326) with a median follow-up of 12.5 years from birth. The risk of a second-appearing autoantibody was independent of GADA versus IAA as a first-appearing autoantibody (adjusted hazard ratio [HR] 1.12; 95% CI 0.88–1.42; P = 0.36). Second-appearing GADA, IAA, IA-2A, or ZnT8A conferred an increased risk of T1D compared with children who remained positive for a single autoantibody, e.g., IAA or GADA second (adjusted HR 6.44; 95% CI 3.78–10.98), IA-2A second (adjusted HR 16.33; 95% CI 9.10–29.29; P < 0.0001), or ZnT8A second (adjusted HR 5.35; 95% CI 2.61–10.95; P < 0.0001). In children who developed a distinct second autoantibody, IA-2A (adjusted HR 3.08; 95% CI 2.04–4.65; P < 0.0001) conferred a greater risk of progression to T1D as compared with GADA or IAA. Additionally, both a younger initial age at seroconversion and shorter time to the development of the second-appearing autoantibody increased the risk for T1D. CONCLUSIONS: The hierarchical order of distinct autoantibody spreading was independent of the first-appearing autoantibody type and was age-dependent and augmented the risk of progression to T1D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In children with only one persistent islet autoantibody, the risk of diabetes within 10 years is 15% while two or more islet autoantibodies predict type 1 diabetes in 70% within 10 years (408,409).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [409]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s081 · Cited by 5,974
Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Self-citationInsel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
Self-citationThe cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes
Wenzlau, J. M., Juhl, K., Yu, L., Moua, O., Sarkar, S. A., Gottlieb, P., Rewers, M., Eisenbarth, G. S., Jensen, J., Davidson, H. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705894104 · Cited by 1,014
Self-citationZiegler, A. G., Hummel, M., Schenker, M., & Bonifacio, E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 645
Self-citationConcannon, P., Rich, S. S., & Nepom, G. T. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0808284 · Cited by 510
Self-citationBingley, P. J., Bonifacio, E., Williams, A. J. K., Genovese, S., Bottazzo, G. F., & Gale, E. A. M. (1997) · Diabetes · doi:10.2337/diab.46.11.1701 · Cited by 461
Self-citationYu, L., Robles, D. T., Abiru, N., Kaur, P., Rewers, M., Kelemen, K., & Eisenbarth, G. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040556697 · Cited by 450
Self-citationthe TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444
Self-citation
Cited by
Chen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Diabetes Care · doi:10.2337/dci23-0036 · Cited by 351
Self-citationSacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 205
Self-citationPhillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E. E., Colhoun, H. M., Couper, J., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06205-5 · Cited by 136
Self-citationKrischer, J. P., Liu, X., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Toppari, J., Ziegler, A.-G., Akolkar, B., TEDDY Study Group, et al. (2022) · Diabetes Care · doi:10.2337/dc21-2612 · Cited by 76
Self-citationAdvances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count
So, M., Speake, C., Steck, A. K., Lundgren, M., Colman, P. G., Palmer, J. P., Herold, K. C., & Greenbaum, C. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab013 · Cited by 80
Self-citationPhillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E., Colhoun, H. M., Couper, J. J., et al. (2024) · Diabetes Care · doi:10.2337/dci24-0042 · Cited by 79
Self-citationMarzinotto, I., Pittman, D. L., Williams, A. J. K., Long, A. E., Achenbach, P., Schlosser, M., Akolkar, B., Winter, W. E., Lampasona, V., & laboratories, P. (2023) · Diabetologia · doi:10.1007/s00125-023-05877-9 · Cited by 76
Self-citationEnteroviruses and Type 1 Diabetes: Multiple Mechanisms and Factors?
Lloyd, R. E., Tamhankar, M., & Lernmark, Å. (2022) · Annual Review of Medicine · doi:10.1146/annurev-med-042320-015952 · Cited by 59
Self-citationFelton, J. L., REDONDO, M. J., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Harris-Kawano, A., Perez, D., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00478-y · Cited by 72
Self-citationNakayasu, E. S., Bramer, L., Ansong, C. K., Schepmoes, A., Fillmore, T., Gritsenko, M., Clauss, T. R., Gao, Y., Piehowski, P., Stanfill, B., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101093 · Cited by 56
Self-citationTeplizumab in Type 1 Diabetes Mellitus: An Updated Review
Thakkar, S., Chopra, A., Nagendra, L., Kalra, S., & Bhattacharya, S. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.2.7 · Cited by 54
Kwon, B. C., Anand, V., Achenbach, P., Dunne, J. L., Hagopian, W., Hu, J., Koski, E., Lernmark, Å., Lundgren, M., Ng, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28909-1 · Cited by 44
Self-citationThompson, P. J., Pipella, J., Rutter, G. A., Gaisano, H. Y., & Santamaría, P. (2023) · Diabetologia · doi:10.1007/s00125-023-05970-z · Cited by 42
Bonifacio, E. E., & Ziegler, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16354 · Cited by 40
Self-citationLind, A., Cortez, F. D. J., Ramelius, A., Bennet, R., Robinson, P. V., Seftel, D., Gebhart, D., Tandel, D., Maziarz, M., Agardh, D., et al. (2022) · Journal of Immunological Methods · doi:10.1016/j.jim.2022.113265 · Cited by 39
Self-citationLooking back at the TEDDY study: lessons and future directions
Lernmark, Å., Agardh, D., Akolkar, B., Gesualdo, P., Hagopian, W., Haller, M. J., Hyöty, H., Johnson, S. B., Larsson, H. E., Liu, E., et al. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01045-0 · Cited by 38
Self-citationGut microbiome in type 1 diabetes: the immunological perspective
Rampanelli, E., & Nieuwdorp, M. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2150612 · Cited by 32
Fyvie, M. J., & Gillespie, K. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1158278 · Cited by 32
Sims, E. K., Cuthbertson, D. D., Ferrat, L. A., Bosi, E., Evans‐Molina, C., DiMeglio, L. A., Nathan, B. M., Ismail, H. M., Jacobsen, L. M., REDONDO, M. J., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06382-x · Cited by 31
Self-citationNew Horizons for Multiple Sclerosis Therapy: 2025 and Beyond
Sabatino, J. J., Cree, B., & Hauser, S. L. (2025) · Annals of Neurology · doi:10.1002/ana.27270 · Cited by 32
Etiology of Autoimmune Islet Disease: Timing Is Everything
Lernmark, Å. (2021) · Diabetes · doi:10.2337/dbi18-0034 · Cited by 27
Self-citationPassanisi, S., Salzano, G., Bombaci, B., & Lombardo, F. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00716-6 · Cited by 27
Antigen-specific immunotherapies in type 1 diabetes
Zhang, X., Dong, Y., Liu, D., Yang, L., Xu, J., & Wang, Q. (2022) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2022.127040 · Cited by 26
Mallone, R., Bismuth, É., Thivolet, C. H., Benhamou, P., Hoffmeister, N., Collet, F., Nicolino, M. P., Reynaud, R., & Beltrand, J. (2024) · Diabetes & Metabolism · doi:10.1016/j.diabet.2024.101603 · Cited by 23
The KAG Motif of HLA-DRB1 (β71, β74, β86) Predicts Seroconversion and Development of Type 1 Diabetes
Zhao, L. P., Papadopoulos, G. K., Lybrand, T. P., Moustakas, A. K., Bondinas, G. P., Carlsson, A., Larsson, H. E., Ludvigsson, J., Marcus, C., Persson, M., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103431 · Cited by 23
Self-citationHarrison, L. C. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101288 · Cited by 22
Sebastiani, G., Grieco, G. E., Bruttini, M., Auddino, S., Mori, A., Toniolli, M., Fignani, D., Licata, G., Aiello, E., Nigi, L., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101591 · Cited by 21
Williams, C. L., Marzinotto, I., Brigatti, C., Gillespie, K. M., The BOX Study Group, Wilson, I. S., Aitken, R. J., Megson, C., Ballav, C., Dutta, A. K., et al. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad139 · Cited by 20
Self-citationRewers, M., Agardh, D., Johnson, S. B., Bonifacio, E. E., Larsson, H. E., Gesualdo, P., Hagopian, W., Haller, M. J., Hyöty, H., Johnson, R. K., et al. (2025) · Diabetes Care · doi:10.2337/dc24-2886 · Cited by 20
Self-citationData-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles
Ghalwash, M. F., Anand, V., Ng, K., Dunne, J. L., Lou, O., Lundgren, M., Hagopian, W., Rewers, M., Ziegler, A. G., Veijola, R., et al. (2024) · Diabetes Care · doi:10.2337/dc24-0198 · Cited by 19
Self-citationSalami, F., Tamura, R., You, L., Lernmark, Å., Larsson, H. E., Lundgren, M., Krischer, J. P., Ziegler, A., Toppari, J., Veijola, R., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13413 · Cited by 19
Self-citationCasu, A., Grippo, P. J., Wasserfall, C. H., Sun, Z., Linsley, P. S., Hamerman, J. A., Fife, B. T., Lacy‐Hulbert, A., Toledo, F. G. S., Hart, P. A., et al. (2022) · Pancreas · doi:10.1097/mpa.0000000000002076 · Cited by 18
Loss of Znt8 function in diabetes mellitus: risk or benefit?
Barragán-Álvarez, C. P., Padilla‐Camberos, E., Díaz, N. F., Cota-Coronado, A., Hernández-Jiménez, C., Bravo‐Reyna, C., & Diaz-Martinez, N. E. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04114-4 · Cited by 18
Four decades of the Bart’s Oxford study: Improved tests to predict type 1 diabetes
Gillespie, K. M., Fareed, R., & Mortimer, G. (2021) · Diabetic Medicine · doi:10.1111/dme.14717 · Cited by 17
Time to reframe the disease staging system for type 1 diabetes
Jacobsen, L. M., Atkinson, M. A., Sosenko, J. M., & Gitelman, S. E. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00239-0 · Cited by 16
Self-citationType 1 Diabetes Genetic Risk Scores: History, Application and Future Directions
Tosur, M., Önengüt-Gümüşcü, S., & REDONDO, M. J. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01575-5 · Cited by 16
Ng, K., Anand, V., Stavropoulos, H., Veijola, R., Toppari, J., Maziarz, M., Lundgren, M., Waugh, K., Frohnert, B. I., Martin, F., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05799-y · Cited by 16
Self-citationEpitope-based precision immunotherapy of Type 1 diabetes
Firdessa-Fite, R., Genzano, C. B., Mallone, R., & Creusot, R. J. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2154098 · Cited by 16
From Prediction to Prevention: The Intricacies of Islet Autoantibodies in Type 1 Diabetes
Khine, A., & Quandt, Z. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01595-1 · Cited by 14
Recognition of mRNA Splice Variant and Secretory Granule Epitopes by CD4+ T Cells in Type 1 Diabetes
Guyer, P., Arribas-Layton, D., Manganaro, A., Speake, C., Lord, S. M., Eizirik, D. L., Kent, S. C., Mallone, R., & James, E. A. (2022) · Diabetes · doi:10.2337/db22-0191 · Cited by 14
100 Years of insulin: Lifesaver, immune target, and potential remedy for prevention
Ziegler, A., Danne, T., Daniel, C., & Bonifacio, E. E. (2021) · Med · doi:10.1016/j.medj.2021.08.003 · Cited by 14
Self-citationZhao, L. P., Papadopoulos, G. K., Skyler, J. S., Pugliese, A., Parikh, H. M., Kwok, W. W., Lybrand, T. P., Bondinas, G. P., Moustakas, A. K., Wang, R., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1947 · Cited by 13
Self-citationUntangling the genetics of beta cell dysfunction and death in type 1 diabetes
Robertson, C. C., Elgamal, R. M., Henry-Kanarek, B. A., Arvan, P., Chen, S., Dhawan, S., Eizirik, D. L., Kaddis, J. S., Vahedi, G., Parker, S. C. J., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101973 · Cited by 13
The heterogeneity of type 1 diabetes: From immunopathology to immune intervention
Infante, M., Alejandro, R., Fabbri, A., & Ricordi, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824466-1.00001-7 · Cited by 12
Mallone, R., Bismuth, É., Thivolet, C., Benhamou, P., Hoffmeister, N., Collet, F., Nicolino, M. P., Reynaud, R., Beltrand, J., Beltrand, J., et al. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.06.003 · Cited by 11
A Historical and Epistemological Review of Type 1 Diabetes Mellitus
Cavalli, E., Nicoletti, G. R. P., & Nicoletti, F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144923 · Cited by 10
Nieto, J., Castillo, B., Astudillo, M., Tosur, M., Balasubramanyam, A., Pietropaolo, M., & REDONDO, M. J. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13238 · Cited by 10
100 YEARS OF INSULIN: Arresting or curing type 1 diabetes: an elusive goal, but closing the gap
Martens, P.-J., Gysemans, C. A., & Mathieu, C. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0552 · Cited by 9
Clinical and experimental treatment of type 1 diabetes
Long, S. A., & Buckner, J. H. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac077 · Cited by 9
Kuusela, S., Koskenniemi, J. J., Valtanen, T., Pokka, T. M.-L., Härkönen, T., Ilonen, J., Lempainen, J., Kyrönniemi, A., Toppari, J., Knip, M., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06573-6 · Cited by 8
Self-citationGreenbaum, C. J., Nepom, G. T., Heickman, L. K. W., Wherrett, D. K., DiMeglio, L. A., Herold, K. C., & Krischer, J. P. (2024) · Diabetes · doi:10.2337/dbi24-0020 · Cited by 8
Self-citationChuzho, N., Kumar, N., Mishra, N., Tandon, N., Kanga, U., Kaur, G., Singh, P., Mishra, G., Sharma, S., & Mehra, N. K. (2021) · Journal of Diabetes Research · doi:10.1155/2021/4012893 · Cited by 8
Screening Strategy for Islet Autoantibodies in Diabetes Patients of Different Ages
Nan, X., Li, X., Xiang, Y., Yan, X., Zhou, H., Tang, X., Cheng, J., Niu, X., Liu, J., Ji, Q., et al. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0177 · Cited by 7
Martinez, M. M., Spiliopoulos, L., Salami, F., Agardh, D., Toppari, J., Lernmark, Å., Kero, J. T., Veijola, R., Tossavainen, P. H., Palmu, S. A., et al. (2021) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-021-00135-6 · Cited by 7
Self-citationLan, Y., Kovinthapillai, R., Kędzia, A. W., & Niechciał, E. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15020533 · Cited by 6
Type 1 Diabetes Screening and Diagnosis
Gomez, P., & Sanchez, J. E. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.09.008 · Cited by 6
Couper, J., Oakey, H., Penno, M. A. S., Wentworth, J. M., Watson, K., Brown, J. D., Huynh, D., Thomson, R. L., Craig, M. E., Davis, E. A., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06591-4 · Cited by 5
Immunotherapy for type 1 diabetes
Sann, K. M., Rahman, M. A., & Thu, M. M. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2024.37 · Cited by 5
Lymph nodes as gatekeepers of autoimmune diseases
O’Byrne, A. M., & van Baarsen, L. G. M. (2024) · RMD Open · doi:10.1136/rmdopen-2024-004097 · Cited by 5
Guyer, P., Seminova, K., Lugar, M., Manganaro, A., de la Cruz, E. V., Hartley, R., Smithmyer, M. E., Speake, C., Bonifacio, E. E., Kent, S. C., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06458-8 · Cited by 5
Self-citationPrevalence of markers of beta cell autoimmunity and thyroid disease in children with coeliac disease
Légeret, C., Kutz, A., Jessica, B., Mundwiler, E., Köhler, H., & Bernasconi, L. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-04294-6 · Cited by 5
Arresting type 1 diabetes: are we there yet? Obstacles and opportunities
Mathieu, C., & Martens, P.-J. (2022) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2022.16 · Cited by 5
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression
Triolo, T. M., Sosenko, J. M., Cuthbertson, D. D., Oram, R. A., Parikh, H. M., Steck, A. K., Sims, E. K., Jacobsen, L. M., Nathan, B. M., Templeman, E. L., et al. (2025) · Diabetes · doi:10.2337/db25-0711 · Cited by 4
Self-citationNew and emerging therapies in type 1 diabetes mellitus
Herold, K. C., & Evans‐Molina, C. (2026) · Journal of Clinical Investigation · doi:10.1172/jci205520 · Cited by 4
Birth Cohorts in Type 1 Diabetes: Preparing for the Payoff
Cossen, K., & MUIR, A. B. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa736 · Cited by 4
Epidemiology and Pathogenesis of Type 1 Diabetes
Stene, L. C., & Lernmark, Å. (2023) · Springer eBooks · doi:10.1007/978-3-031-20999-4_2 · Cited by 4
Self-citationYou, L., Salami, F., Tamura, R., Törn, C., Vehik, K., Hagopian, W., Rewers, M., McIndoe, R., Toppari, J., Ziegler, A., et al. (2025) · Pediatric Diabetes · doi:10.1155/pedi/8845330 · Cited by 3
Self-citationAkel, O., & Lernmark, Å. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch14 · Cited by 3
Self-citationPhillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E. E., Colhoun, H. M., Couper, J., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06266-6 · Cited by 3
Self-citationBoettcher, C., Holl, R. W., Nagl, K., Karges, B., von Sengbusch, S., Welters, A., Warncke, K., Flury, M., Nahdiyati, D., Berge, T. V. D., et al. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005349 · Cited by 2
Self-citationAge and sex mark clinical differences in the presentation of pediatric type 1 diabetes mellitus
Gupta, E. A., Huang, X., VELASQUEZ, H. J., Golani, K., Siller, A. F., Minard, C. G., Tosur, M., & REDONDO, M. J. (2024) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0451 · Cited by 2
Георгиевна, К. К., Da, C., Strongin, L. G., & Загайнов, В. Е. (2025) · Russian Medicine · doi:10.17816/medjrf686278 · Cited by 1
Williams, M. D., Grace, C. R., Posgai, A. L., MCGRAIL, K. M., Brusko, M., Haller, M. J., Jacobsen, L. M., Schatz, D., Brusko, T. M., Atkinson, M. A., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2024-004655 · Cited by 1
Self-citationNakhleh, A., Beeri, G., Sudri, O., Rotkopf, S., & Shehadeh, N. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71044 · Cited by 1
Попова, В. В., Het’man, N. V., Labanets, Y. I., Kulikovska, H. V., Furmanova, O. V., & Kp, Z. (2023) · Endokrynologia · doi:10.31793/1680-1466.2023.28-1.36 · Cited by 1
Jönsson, J., & Lernmark, Å. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00176-9 · Cited by 1
Self-citationData from a multi-year targeted proteomics study of a longitudinal birth cohort of type 1 diabetes
Bramer, L., Nakayasu, E. S., Flores, J. E., Eyk, J. E. V., MacCoss, M. J., Parikh, H. M., Metz, T., & Webb‐Robertson, B. (2025) · Scientific Data · doi:10.1038/s41597-024-04249-1 · Cited by 1
Self-citationThe clinical approach to diabetic pediatric patients
Medeşan, A.-M., Grama, A., & Micu, M.-A. (2023) · Medic ro · doi:10.26416/med.153.3.2023.8188
Maziarz, M., Koskenniemi, J. J., Martinez, M. M., Spiliopoulos, L., Salami, F., Toppari, J., Kero, J. T., Veijola, R., Tossavainen, P. H., Palmu, S. A., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf073
Self-citationScreening, staging, and beta cell function preservation strategies in patients with type 1 DM
Ruyatkina, L. A., Анмут, В. М., & Коваренко, М. А. (2025) · JOURNAL of SIBERIAN MEDICAL SCIENCES · doi:10.31549/2542-1174-2025-9-3-80-95
Phillip, M., Achenbach, P., Addala, A., Albanese-O’Neill, A., Battelino, T., Bell, K. J., Besser, R. E. J., Bonifacio, E., Colhoun, H. M., Couper, J. J., et al. (2024) · Apollo (University of Cambridge) · doi:10.17863/cam.108567
Self-citationMartinez, M. M., Spiliopoulos, L., Salami, F., Agardh, D., Toppari, J., Lernmark, Å., Kero, J. T., Veijola, R., Tossavainen, P. H., Palmu, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.17870244
Self-citationMulti-omics analysis of early molecular mechanisms of type 1 diabetes
Laajala, E. (2021) · UTUPub (University of Turku)
Nieuwe immunotherapieën ter preventie of genezing van type 1 diabetes
Martens, P.-J. (2023) · Lirias
Early immune response in children developing type 1 diabetes
Starskaia, I. (2025) · UTUPub (University of Turku)
Immunological mechanisms in the pathogenesis of type 1 diabetes
Valta, M. (2023) · UTUPub (University of Turku)
寺田, 啓. (2024) · Institutional Repositories DataBase (IRDB) · doi:10.15006/0002002182
Parsian, P., Bennet, R., Tsai, C., Ramelius, A., Lernmark, Å., Jönsson, J., the BDD Study Group, Lind, A., Hamdan, S., Carlsson, A., et al. (2026) · Clinical & Experimental Immunology · doi:10.1093/cei/uxag026
Self-citationEsparza, D., Jayasena, C. S., Jovanović‐Talisman, T., & Thurmond, D. C. (2026) · Comprehensive physiology · doi:10.1002/cph4.70198
You, L., Salami, F., Törn, C., Lernmark, Å., Vehik, K., Liu, X., Qiu, P., & Tamura, R. (2026) · Biostatistics · doi:10.1093/biostatistics/kxag018
Self-citationScreening and Monitoring for Presymptomatic Type 1 Diabetes: A Time for Action
Sims, E. K., Mathieu, C., Ziegler, A., Rewers, M., Ebekozien, O. A., Agardh, D., Bosi, E., Chatenoud, L., Oram, R. A., & Dutta, S. (2026) · Hormone Research in Paediatrics · doi:10.1159/000552602
Self-citationOnengut-Gumuscu, S., & REDONDO, M. J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-11985-9.00014-7
Self-citationAbujlambo, A. I., Nabaa, S., Woldemeskel, M., Cutaia, J., Zaidi, M., Ferdous, S., Aung, T., Asfand, S., War, N. N. W., Pulpandi, S., et al. (2026) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-026-00687-y
Stage‐Adapted Disease‐Modifying Therapy in Type 1 Diabetes
Ye, C., Jin, Z., & Hu, S. S. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71210
Yaneva, N. Y., Popov, T. T., Petrova, M., Yordanova, A., Arshinkova, M., Kyurkchiev, D. S., & Kurteva, E. K. (2026) · Life · doi:10.3390/life16091500
Type I Diabetes Results from Immune Cell Invasion into Pancreatic Islets
Beck, M. G. (2023) · Civil War Book Review
Role of Islet Autoantibodies in Type 1 Diabetes: A Review Article
Baseer, K. A. A., Elsaied, A. A., Ebrahim, E. A. M., & Abd-Elmawgood, E. A. (2025) · International Journal of Environmental Sciences · doi:10.64252/eq57c565
Decoding autoimmune diseases through the adaptive immune receptor repertoires
Wang, X., 朱华群, Li, Z., & Cao, L. (2026) · Autoimmunity Reviews · doi:10.1016/j.autrev.2026.104201
Metadata
- Authors
- Vehik, K., Bonifacio, E., Lernmark, Å., Yu, L., Williams, A., Schatz, D., Rewers, M., She, J.-X., Toppari, J., Hagopian, W., Akolkar, B., Ziegler, A. G., Krischer, J. P., The TEDDY Study Group, Rewers, M., Barbour, A., Bautista, K., Baxter, J., Felipe-Morales, D., Driscoll, K., Frohnert, B. I., Stahl, M., Gesualdo, P., Hoffman, M., Karban, R., Liu, E., Norris, J., Peacock, S., Shorrosh, H., Steck, A., Stern, M., Villegas, E., Waugh, K., Toppari, J., . Simell, O. G., Adamsson, A., Ahonen, S., Åkerlund, M., Hakola, L., Hekkala, A., Holappa, H., Hyöty, H., Ikonen, A., Ilonen, J., Jäminki, S., Jokipuu, S., Karlsson, L., Kero, J., Kähönen, M., Knip, M., Koivikko, M.-L., Koskinen, M., Koreasalo, M., Kurppa, K., Kytölä, J., Latva-aho, T., Lindfors, K., Lönnrot, M., Mäntymäki, E., Mattila, M., Miettinen, M., Multasuo, K., Mykkänen, T., Niininen, T., Niinistö, S., Nyblom, M., Oikarinen, S., Ollikainen, P., Othmani, Z., Pohjola, S., Rajala, P., Rautanen, J., Riikonen, A., Riski, E., Pekkola, M., Romo, M., Ruohonen, S., Simell, S., Sjöberg, M., Stenius, A., Tossavainen, P., Vähä-Mäkilä, M., Vainionpää, S., Varjonen, E., Veijola, R., Viinikangas, I., Virtanen, S. M., She, J.-X., Schatz, D., Hopkins, D., Steed, L., Bryant, J., Silvis, K., Haller, M., Gardiner, M., McIndoe, R., Sharma, A., Anderson, S. W., Jacobsen, L., Marks, J., Towe, P. D., Ziegler, A. G., Bonifacio, E., Gezginci, C., Heublein, A., Hohoff, E., Hummel, S., Knopff, A., Koch, C., Koletzko, S., Ramminger, C., Roth, R., Schmidt, J., Scholz, M., Stock, J., Warncke, K., Wendel, L., Winkler, C., Lernmark, Å., Agardh, D., Andrén Aronsson, C., Ask, M., Bennet, R., Cilio, C., Dahlberg, S., Engqvist, H., Ericson-Hallström, E., Björne Fors, A., Fransson, L., Gard, T., Hansen, M., Jisser, H., Johansen, F., Jonsdottir, B., Elding Larsson, H., Lindström, M., Lundgren, M., Maziarz, M., Månsson-Martinez, M., Melin, J., Mestan, Z., Nilsson, C., Ottosson, K., Rahmati, K., Ramelius, A., Salami, F., Sjöberg, A., Sjöberg, B., Törn, C., Wimar, Å., Hagopian, W. A., Killian, M., Cowen Crouch, C., Skidmore, J., Chavoshi, M., Meyer, A., Meyer, J., Mulenga, D., Powell, N., Radtke, J., Romancik, M., Roy, S., Schmitt, D., Zink, S., Becker, D., Franciscus, M., Dalmagro-Elias Smith, M., Daftary, A., Beth Klein, M., Yates, C., Krischer, J. P., Austin-Gonzalez, S., Avendano, M., Baethke, S., Burkhardt, B., Butterworth, M., Clasen, J., Cuthbertson, D., Eberhard, C., Fiske, S., Garmeson, J., Gowda, V., Heyman, K., Hsiao, B., Karges, C., Perez Laras, F., Li, Q., Liu, S., Liu, X., Lynch, K., Maguire, C., Malloy, J., McCarthy, C., Parikh, H., Remedios, C., Shaffer, C., Smith, L., Smith, S., Sulman, N., Tamura, R., Tewey, D., Toth, M., Uusitalo, U., Vehik, K., Vijayakandipan, P., Yang, J., Abbondondolo, M., Ballard, L., Brown, R., Dankyi, S., Hadley, D., Lee, H.-S., McLeod, W., Merrell, A., Meulemans, S., Quigley, R., Akolkar, B., Yu, L., Miao, D., Bingley, P., Williams, A., Chandler, K., Kelland, I., Ben Khoud, Y., Zahid, H., Randell, M., Hagopian, W., Chavoshi, M., Radtke, J., Zink, S., Erlich, H., Mack, S. J., Lisa Fear, A., Rich, S. S., Chen, W.-M., Onengut-Gumuscu, S., Farber, E., Roche Pickin, R., Davis, J., Davis, J., Gallo, D., Bonnie, J., Campolieto, P., Ke, S., Mulholland, N., Bourcier, K., Briese, T., Bennett Johnson, S., & Triplett, E.
- Affiliations
- University of Colorado Anschutz (US)
- University of Turku (FI)
- Augusta University (US)
- TUM Klinikum (DE)
- Lund University (SE)
- Pacific Northwest Research Institute (US)
- University of South Florida (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- University of Bristol (GB)
- ORCID
- Driscoll, Kimberly
- Frohnert, Brigitte I.
- Gesualdo, Patricia
- Liu, Edwin
- Norris, Jill
- Steck, Andrea
- Adamsson, Annika
- Hakola, Leena
- Hekkala, Anne
- Hyöty, Heikki
- Ilonen, Jorma
- Kero, Jukka
- Knip, Mikael
- Kurppa, Kalle
- Lindfors, Katri
- Lönnrot, Maria
- Mattila, Markus
- Miettinen, Maija
- Niinistö, Sari
- Oikarinen, Sami
- Riikonen, Anne
- Tossavainen, Päivi
- Vähä-Mäkilä, Mari
- Veijola, Riitta
- Virtanen, Suvi M.
- Hopkins, Diane
- Steed, Leigh
- Silvis, Katherine
- Haller, Michael
- McIndoe, Richard
- Sharma, Ashok
- Jacobsen, Laura
- Heublein, Anja
- Hohoff, Eva
- Hummel, Sandra
- Roth, Roswith
- Schmidt, Jennifer
- Warncke, Katharina
- Winkler, Christiane
- Agardh, Daniel
- Bennet, Rasmus
- Cilio, Corrado
- Lundgren, Markus
- Maziarz, Marlena
- Melin, Jessica
- Ramelius, Anita
- Salami, Falastin
- Törn, Carina
- Skidmore, Jennifer
- Roy, Shreya
- Burkhardt, Brant
- Clasen, Joanna
- Cuthbertson, David
- Heyman, Kathleen
- Li, Qian
- Liu, Xiang
- Lynch, Kristian
- Parikh, Hemang
- Remedios, Cassandra
- Uusitalo, Ulla
- Yang, Jimin
- Lee, Hye-Seung
- Quigley, Ryan
- Chandler, Kyla
- Mack, Steven J.
- Rich, Stephen S.
- Chen, Wei-Min
- Farber, Emily
- Davis, Jonathan
- Bonnie, Jessica
- Briese, Thomas
- Triplett, Eric
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-07-08
- Volume
- 43
- Issue
- 9
- Pages
- 2066-2073
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC7440899
- OpenAlex
- W3041031234
- Cited by
- 87
- References
- 43
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 17 · 2023: 15 · 2022: 13 · 2021: 14 · 2020: 1
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes Care (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (acceptedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Site cant be reached (submittedVersion, other-oa)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (U01-DK-63829, U01-DK-63861, U01-DK-63821, U01-DK-63865, U01-DK-63863, U01-DK-63836, U01-DK-63790, U01-DK-100238, U01-DK-106955, U01-DK-112243, U01-DK-117483, U01-DK-95300, UC4-DK-63829, UC4-DK-63861, UC4-DK-63821, UC4-DK-63865, UC4-DK-63863, UC4-DK-63836, UC4-DK-95300, UC4-DK-100238, UC4-DK-106955, UC4-DK-112243, UC4-DK-117483, contract no. HHSN267200700014C)
- National Institute of Allergy and Infectious Diseases
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- National Institute of Environmental Health Sciences
- JDRF
- Centers for Disease Control and Prevention
- National Institutes of Health/National Center for Advancing Translational Sciences (UL1-TR-000064, UL1-TR-001082)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, beta-cell autoantibodies, glutamic acid decarboxylase antibodies, zinc transporter 8 autoantibodies, TEDDY study, disease risk stratification
- MeSH terms
- Seroconversion, Zinc Transporter 8, Adolescent, Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glutamate Decarboxylase, HLA-DQ Antigens, HLA-DR Antigens, Humans, Infant, Insulin Antibodies, Male, Risk Factors, Disease Progression, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.